RCT of a decision support tool for the assessment of absolute cardiovascular risk in general practice.
Nicholas Zwar , David Peiris (George Institute), Anushka Patel (George Institute), Dr Tim Underwood
Through use of the HealthTracker tool
(1) An increased proportion of patients will receive appropriate (guidelines-indicated) measurements of their CVD risk factors.
(2) An increased proportion of patients at high risk will receiving appropriate (guidelines-indicated) prescriptions for management of their CVD risk.
The TORPEDO study will assess whether the HealthTracker-CVD system will assist health professionals and patients in making evidence based management decisions to help prevent heart attack, stroke and related conditions.
12 month cluster randomised controlled trial (RCT) design incorporating 60 sites (30 intervention and 30 control) from 40 general practices and 20 Aboriginal Community Controlled Health Services.
Mark Harris Phone: 02 9385 1547 Email: firstname.lastname@example.org
The George Institute , University of Sydney